Insights from 2023 ESMO Annual Meeting

 

Insights from 2023 ESMO Annual Meeting
S

ESMO 2023 Insights: "DESTINY-Breast04 Study Updated Survival Results - T-DXd vs. Treatment of Physician’s Choice in Patients With HER2-Low Unresectable and/or Metastatic Breast Cancer"

By Insights from 2023 ESMO Annual Meeting FEATURING Shanu Modi
By Insights from 2023 ESMO Annual Meeting FEATURING Shanu Modi
0 views
November 3, 2023
Comments 0
Login to view comments. Click here to Login
Breast
20:10
Insights from 2023 ESMO Annual Meeting

Systemic Therapy of CNS Disease in HER2+ BC

Feat. S. Lee
09:54
Insights from 2023 ESMO Annual Meeting

Adjuvant Abemaciclib + Endocrine Therapy for HR+, HER2- High-Risk eB…

Feat. J. Huober
06:55
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "EMBER Study - Imlunestrant+/-Everolimus or…

Feat. K. Jhaveri
04:41
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Association of TILs With Recurrence Score i…

Feat. F. Miglietta
13:35
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "The RIGHT Choice Trial - 1L Ribociclib + E…

Feat. H. Azim
09:30
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "The CLEVER Trial - Targeting Disseminated D…

Feat. A. DeMichele
13:23
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "A Pooled Analysis of T-DXd for HER2+ mBC Wi…

Feat. S. Hurvitz
30:46
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Panel Discussion: "Metastatic Breast Cancer"

Feat. S. Tolaney, H. Rugo
17:20
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Top 5 Breast Cancer Studies Including KEYNO…

Feat. P. Tarantino
50:59
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Panel Discussion: "Early Stage Breast Cancer"

Feat. S. Tolaney, H. Rugo
05:21
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "TULIP Trial - Trastuzumab Duocarmazine vs.…

Feat. P. Aftimos
08:19
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "DESTINY-Breast04 Study Updated Survival Re…

Feat. S. Modi
07:03
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Multiparametric Prognostic Score in HR+/HE…

Feat. O. Gluz
09:14
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Omission of Breast Surgery After Neoadjuva…

Feat. H. Kuerer